专题:Hormonal Regulation and Hypertension

This cluster of papers focuses on the management, diagnosis, and treatment of Primary Aldosteronism, a condition characterized by the overproduction of aldosterone by the adrenal glands. The research covers topics such as case detection, cardiovascular events, glucocorticoid and mineralocorticoid receptor actions, hypertension, and the use of spironolactone therapy. Additionally, it explores the association with metabolic syndrome and renal injury.
最新文献
Angiotensin Converting Enzyme 2 (ACE2) G8790A Gene Polymorphism as a Risk Factor for Essential Hypertension

article Full Text OpenAlex

Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials

review Full Text OpenAlex

Determination of Multi‐Steroid Profiles of Cats With Hyperaldosteronism or Other Diseases: A Retrospective Study

article Full Text OpenAlex

High Plasma Renin and Aldosterone Levels Are Associated With a Unique Phenotype in Primary Hypertension

article Full Text OpenAlex

Prevalence and Levels of Thyroid Autoantibodies in Polycystic Ovary Syndrome—Impact of TSH- and BMI-Matched Comparisons: A Systematic Review and Meta-Analysis

review Full Text OpenAlex

Safety of esaxerenone (CS-3150) and its impacts on blood pressure and renal function: A systematic review and meta-analysis

review Full Text OpenAlex

Effects of sacubitril/valsartan on hypertensive heart disease: the REVERSE-LVH randomized phase 2 trial

article Full Text OpenAlex

Blinded Withdrawal of Finerenone After Long-Term Treatment in the FINEARTS-HF Trial

article Full Text OpenAlex

Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases

review Full Text OpenAlex

Relationships of markers of heart injury, overload, and inflammation with cardiac fibrosis in patients with primary aldosteronism

article Full Text OpenAlex

近5年高被引文献
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

article Full Text OpenAlex 780 FWCI107.891

A non-canonical vitamin K cycle is a potent ferroptosis suppressor

article Full Text OpenAlex 501 FWCI68.221

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

article Full Text OpenAlex 469 FWCI162.014

European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors

article Full Text OpenAlex 352 FWCI156.332

Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

article Full Text OpenAlex 300 FWCI205.091

Personalized Management of Pheochromocytoma and Paraganglioma

review Full Text OpenAlex 289 FWCI16.209

Adrenal insufficiency

review Full Text OpenAlex 266 FWCI9.904

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis

article Full Text OpenAlex 243 FWCI33.732

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension

article Full Text OpenAlex 241 FWCI46.65

Diagnosis and treatment of primary aldosteronism

review Full Text OpenAlex 233 FWCI7.548